| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/23/1997 | US5670501 Useful as diuretics, treating renal disorders, restoring cardiac functions |
| 09/23/1997 | US5670499 Physiological disorders, gastrointestinal disorders, antiinflammatory agents |
| 09/23/1997 | US5670482 Neuropeptide Y antagonists |
| 09/23/1997 | US5670342 Stimulate the proliferation and differentiation of colon epithelial cells |
| 09/18/1997 | WO1997033996A2 Human bikunin |
| 09/18/1997 | WO1997033911A1 Persephin and related growth factors |
| 09/18/1997 | WO1997033889A1 NOVEL IMIDAZO[1,5-c]QUINAZOLINES; A NEW CLASS OF GABA BRAIN RECEPTOR LIGANDS |
| 09/18/1997 | WO1997033883A1 Novel pyrimidine compounds useful in treating cytokine mediated diseases |
| 09/18/1997 | WO1997033861A1 Anticonvulsant enantiomeric amino acid derivatives |
| 09/18/1997 | WO1997033860A1 Method and compositions for producing analgesia |
| 09/18/1997 | WO1997033859A1 Novel bridged cyclic amino acids as pharmaceutical agents |
| 09/18/1997 | WO1997033858A1 Novel substituted cyclic amino acids as pharmaceutical agents |
| 09/18/1997 | WO1997033609A1 VASOACTIVE EFFECTS AND FREE RADICAL GENERATION BY β-AMYLOID PEPTIDES |
| 09/18/1997 | WO1997033587A1 Method for treating insomnia |
| 09/18/1997 | WO1997033586A1 Method for treating substance abuse |
| 09/18/1997 | WO1997033585A1 Method for treating autism |
| 09/18/1997 | WO1997033581A1 Smoking cessation treatments using naltrexone and related compounds |
| 09/18/1997 | WO1997033577A1 Method for treating bipolar disorder |
| 09/18/1997 | WO1997033574A1 Sustained-release metal valproate tablets |
| 09/18/1997 | WO1997033572A1 Method for preventing and treating peripheral neurophathy by administering selegiline |
| 09/18/1997 | WO1997033550A2 Methods and compositions for diagnosis and treatment of pathological conditions related to abnormal dopamine receptor expression |
| 09/18/1997 | WO1997026866A3 Preparations of non-steroidal analgesics |
| 09/18/1997 | WO1997022695A3 Nucleotide sequences, proteins, drugs and diagnostic agents for treating cancer |
| 09/18/1997 | CA2248758A1 Method for treating insomnia |
| 09/18/1997 | CA2248741A1 Use of olanzapine for treating autism |
| 09/18/1997 | CA2248738A1 Use of olanzapine for treating substance abuse |
| 09/18/1997 | CA2248673A1 Method and compositions for producing analgesia |
| 09/18/1997 | CA2248613A1 Vasoactive effects and free radical generation by .beta.-amyloid peptides |
| 09/18/1997 | CA2247888A1 Human bikunin |
| 09/18/1997 | CA2225913A1 Persephin and related growth factors |
| 09/18/1997 | CA2220768A1 Smoking cessation treatments using naltrexone and related compounds |
| 09/17/1997 | EP0795330A1 Medicament for the treatment of insomnia |
| 09/17/1997 | EP0795017A1 Hippocampus-associated proteins, dna sequences coding therefor and uses thereof |
| 09/17/1997 | EP0794949A1 Novel 3,5-dioxo-(2h,4h)-1,2,4-triazine derivatives, their preparation and use as drugs |
| 09/17/1997 | EP0794944A1 Perhydroisoindole derivatives as antagonists of substance p |
| 09/17/1997 | EP0794942A1 Substituted biphenyl compounds for the treatment of inflammation |
| 09/17/1997 | EP0794791A1 New therapeutical utilization of superoxide dismutases |
| 09/17/1997 | EP0755675B1 Dermatological and/or pharmaceutical composition, process of preparation and utilization |
| 09/17/1997 | EP0696283B1 2-, 3-, 4-, 5-, 6-, 7-, 8-, 9- and/or 10-substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
| 09/17/1997 | EP0639275B1 NOVEL GABAa RECEPTOR SUBTYPES AND METHODS FOR SCREENING DRUG COMPOUNDS USING IMIDAZOQUINOXALINES AND PYRROLOPYRIMIDINES TO BIND TO GABAa RECEPTOR SUBTYPES |
| 09/17/1997 | EP0635009B1 Novel derivatives of 2,3-dihydro-2,2,4,6,7-pentaalkyl-5-benzofuranols |
| 09/17/1997 | EP0607128B1 Drugs, their manufacture, and their use as painkillers and/or to treat inflammations in humans and animals |
| 09/17/1997 | CN1159808A Spiro-azabicyclic compounds useful in therapy |
| 09/17/1997 | CN1159807A New heterocyclic substituted imidazoloquinoxalinones their preparation and their use |
| 09/17/1997 | CN1159804A Dihydrobenzofuranes |
| 09/17/1997 | CN1159801A Colchicine derivatives and the therapeutical use thereof |
| 09/17/1997 | CN1159797A Aryloxy and arylthiopropanolamine derivative suseful as beta 3-adrenoreceptor agonists and antagonists of the beta 1 and beta 2-adrenoreceptors and pharmaceutical composition thereof |
| 09/17/1997 | CN1159754A Improved pharmaceutical formulations containing ibuprofen and codeine |
| 09/17/1997 | CN1159345A Traditional Chinese medicine of set prescription with function of promoting intelligence and prolonging life-span |
| 09/17/1997 | CN1159325A Co-therapy for Parkinson's syndrome |
| 09/16/1997 | US5668282 4,5-cyclicimidazo[1,5-A]quinoxalines |
| 09/16/1997 | US5668279 Treatment of central nervous system diorders and gastrointestinal disorders |
| 09/16/1997 | US5668181 Use of the R-enantiomers of N-propargyl-1-aminoindan compounds for the treatment of depression |
| 09/16/1997 | US5668180 Alkoxyaryl compounds |
| 09/16/1997 | US5668152 Protein kinase C inhibitors |
| 09/16/1997 | US5668151 Useful as anorexigenic agents in promoting weight loss and treating eating disorders |
| 09/16/1997 | US5668144 Muscarinic agents |
| 09/16/1997 | US5668143 Heterocyclic benzenesulfonylimine derivatives as inhibitors of IL-1 action |
| 09/16/1997 | US5668142 Tetracyclic piperidine and 1,4-oxazine compounds |
| 09/16/1997 | US5668138 Affinity for sigma receptors, central nervous system disorders |
| 09/16/1997 | US5668129 N-substituted azaheterocyclic carboxylic acids and esters thereof |
| 09/16/1997 | US5668117 Nervous system disorders using aromatic acid compounds |
| 09/16/1997 | US5667805 Morphine therapy |
| 09/16/1997 | US5667780 Sensory and motor neuron derived factor and binding |
| 09/16/1997 | CA1339463C Effervescent tablet containing a salicylic acid-forming agent |
| 09/12/1997 | WO1997032996A1 Direct molecular diagnosis of friedreich ataxia |
| 09/12/1997 | WO1997032989A2 Recombinant aav vector-based transduction system and use of same |
| 09/12/1997 | WO1997032895A1 Methods of alleviating neuropathic pain using prosaposin-derived peptides |
| 09/12/1997 | WO1997032883A1 Azolobenzazepine derivatives as neurologically active agents |
| 09/12/1997 | WO1997032873A1 Quinoxalinediones |
| 09/12/1997 | WO1997032871A1 Tricyclic compounds, their production and use |
| 09/12/1997 | WO1997032870A1 2-aminoethyl-benzofuran derivatives, preparation thereof and therapeutical use thereof |
| 09/12/1997 | WO1997032865A1 Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds |
| 09/12/1997 | WO1997032858A1 Quinoxaline derivatives as glutamate receptor antagonists |
| 09/12/1997 | WO1997032857A1 Kappa agonist compounds and pharmaceutical formulations thereof |
| 09/12/1997 | WO1997032844A1 Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors |
| 09/12/1997 | WO1997032581A1 Use of 4-phenyl-3,6-dihydro-2h-pyridyl derivatives as nmda receptor subtype blockers |
| 09/12/1997 | WO1997032575A1 Mercapto derivatives as inhibitors of cyclooxygenases |
| 09/12/1997 | WO1997025421A3 PROTEIN INDUCED BY DEPRENYL$m(3) |
| 09/12/1997 | WO1997021416A3 Glycoconjugates of opiated substances |
| 09/12/1997 | CA2248134A1 Use of 4-phenyl-3,6-dihydro-2h-pyridyl derivatives as nmda receptor subtype blockers |
| 09/12/1997 | CA2247453A1 Azolobenzazepine derivatives as neurologically active agents |
| 09/11/1997 | DE19608665A1 Neue Arylglycinamidderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen New Arylglycinamidderivate, processes for their preparation containing these compounds and pharmaceutical compositions |
| 09/10/1997 | EP0794172A1 Orthosubstituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic agent and a medicament containing them |
| 09/10/1997 | EP0793665A1 Heterocyclic compounds and their preparation and use |
| 09/10/1997 | EP0793664A1 Morphine and codeine derivatives for use in therapy |
| 09/10/1997 | EP0793663A1 (thiophen-2-yl)-piperidin or tetrahydropyridin carboxamides |
| 09/10/1997 | EP0793662A1 Aminomethyl aryl compounds; dopamine receptor subtype selective ligands |
| 09/10/1997 | EP0793661A1 Piperazine, piperidine & tetrahydropyridine derivatives useful as 5-ht1 receptor agonists |
| 09/10/1997 | EP0793653A1 Certain 4-aminomethyl-2-substituted imidazole derivatives and 2-aminomethyl-4-substituted imidazole derivatives; new classes of dopamine receptor subtype specific ligands |
| 09/10/1997 | EP0793502A1 Novel hedgehog-derived polypeptides |
| 09/10/1997 | EP0793500A1 Pharmaceutical compositions comprising nitric oxide-releasing biopolymers |
| 09/10/1997 | EP0664807B1 Quinoxalinedione derivatives as eaa antagonists |
| 09/10/1997 | CN1159196A Inhibitors of interleukin-1'beta' converting enzyme |
| 09/10/1997 | CN1158847A New 4-imidazolidinone compound, process for its preparation and pharmaceutical compositions which contain it |
| 09/10/1997 | CN1158725A Use of 8,9-dehydroestrone as antioxidant |
| 09/09/1997 | US5665886 Neurokinin receptor antagonists |
| 09/09/1997 | US5665883 Treatment of pain, inflammation, migraine, emesis |
| 09/09/1997 | US5665774 Treatment of autoimmune diseases |
| 09/09/1997 | US5665765 5,6,7,8-tetrahydronaphtho[2,3-b]furan and indano[5,6-b]furan amine compounds |